These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 22573407

  • 1. Tiam1 is associated with hepatocellular carcinoma metastasis.
    Huang J, Ye X, Guan J, Chen B, Li Q, Zheng X, Liu L, Wang S, Ding Y, Ding Y, Chen L.
    Int J Cancer; 2013 Jan 01; 132(1):90-100. PubMed ID: 22573407
    [Abstract] [Full Text] [Related]

  • 2. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer.
    Chen JS, Su IJ, Leu YW, Young KC, Sun HS.
    Int J Cancer; 2012 Mar 15; 130(6):1302-13. PubMed ID: 21469146
    [Abstract] [Full Text] [Related]

  • 3. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
    Zhang Y, Huang J, Li Q, Chen K, Liang Y, Zhan Z, Ye F, Ni W, Chen L, Ding Y.
    BMC Cancer; 2018 May 08; 18(1):539. PubMed ID: 29739365
    [Abstract] [Full Text] [Related]

  • 4. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q.
    BMC Cancer; 2014 Dec 12; 14():938. PubMed ID: 25494879
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ding Y, Chen B, Wang S, Zhao L, Chen J, Ding Y, Chen L, Luo R.
    Int J Cancer; 2009 Feb 01; 124(3):653-8. PubMed ID: 18972435
    [Abstract] [Full Text] [Related]

  • 6. MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1.
    Liu Y, Ding Y, Huang J, Wang S, Ni W, Guan J, Li Q, Zhang Y, Ding Y, Chen B, Chen L.
    PLoS One; 2014 Feb 01; 9(2):e88393. PubMed ID: 24551096
    [Abstract] [Full Text] [Related]

  • 7. Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.
    Huang YH, Lin YH, Chi HC, Liao CH, Liao CJ, Wu SM, Chen CY, Tseng YH, Tsai CY, Lin SY, Hung YT, Wang CJ, Lin CD, Lin KH.
    Cancer Res; 2013 Apr 15; 73(8):2505-17. PubMed ID: 23442323
    [Abstract] [Full Text] [Related]

  • 8. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
    Tse EY, Ko FC, Tung EK, Chan LK, Lee TK, Ngan ES, Man K, Wong AS, Ng IO, Yam JW.
    J Pathol; 2012 Mar 15; 226(4):645-53. PubMed ID: 22072235
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W, Wu F, Fang F, Tao Y, Yang L.
    Clin Cancer Res; 2008 Nov 01; 14(21):6804-12. PubMed ID: 18980974
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinoma.
    Li W, Liang Y, Yang B, Sun H, Wu W.
    J Gastroenterol Hepatol; 2015 Jun 01; 30(6):1085-93. PubMed ID: 25611915
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma.
    Yang W, Lv S, Liu X, Liu H, Yang W, Hu F.
    Jpn J Clin Oncol; 2010 Nov 01; 40(11):1053-9. PubMed ID: 20522449
    [Abstract] [Full Text] [Related]

  • 12. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
    Gao L, Ge C, Fang T, Zhao F, Chen T, Yao M, Li J, Li H.
    J Gastroenterol Hepatol; 2015 Feb 01; 30(2):396-404. PubMed ID: 25090954
    [Abstract] [Full Text] [Related]

  • 13. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.
    Fang T, Cui M, Sun J, Ge C, Zhao F, Zhang L, Tian H, Zhang L, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li H, Li J.
    Oncotarget; 2015 Jun 30; 6(18):16106-19. PubMed ID: 25965830
    [Abstract] [Full Text] [Related]

  • 14. B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice.
    Wang J, Dong L, Xu L, Chu ES, Chen Y, Shen J, Li X, Wong CC, Sung JJ, Yu J.
    Cancer Lett; 2014 Dec 28; 355(2):192-200. PubMed ID: 25218345
    [Abstract] [Full Text] [Related]

  • 15. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X, Li YF, Chen GD, Ou DP, Qiu XX, Zuo CH, Yang LY.
    Oncotarget; 2015 Dec 01; 6(38):40622-41. PubMed ID: 26536663
    [Abstract] [Full Text] [Related]

  • 16. Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis.
    Wang W, Wang Q, Huang DB, Sun QK, Wu SS, Zhao YJ, Jia W, Hu DS, He YF.
    Cancer Lett; 2021 Apr 10; 503():19-31. PubMed ID: 33472090
    [Abstract] [Full Text] [Related]

  • 17. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
    Lai TY, Su CC, Kuo WW, Yeh YL, Kuo WH, Tsai FJ, Tsai CH, Weng YJ, Huang CY, Chen LM.
    Oncol Rep; 2011 Aug 10; 26(2):415-22. PubMed ID: 21617877
    [Abstract] [Full Text] [Related]

  • 18. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
    Chen J, Xia H, Zhang X, Karthik S, Pratap SV, Ooi LL, Hong W, Hui KM.
    J Hepatol; 2015 Jun 10; 62(6):1287-95. PubMed ID: 25617497
    [Abstract] [Full Text] [Related]

  • 19. SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.
    Lv X, Yu H, Zhang Q, Huang Q, Hong X, Yu T, Lan H, Mei C, Zhang W, Luo H, Pang P, Shan H.
    J Cell Mol Med; 2020 Sep 10; 24(18):10714-10729. PubMed ID: 32746503
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.
    Hao C, Zhu PX, Yang X, Han ZP, Jiang JH, Zong C, Zhang XG, Liu WT, Zhao QD, Fan TT, Zhang L, Wei LX.
    BMC Cancer; 2014 Dec 18; 14():978. PubMed ID: 25522783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.